DE602006010432D1 - Carbamatverbindungen als agonisten am 5-ht4-rezeptor - Google Patents

Carbamatverbindungen als agonisten am 5-ht4-rezeptor

Info

Publication number
DE602006010432D1
DE602006010432D1 DE602006010432T DE602006010432T DE602006010432D1 DE 602006010432 D1 DE602006010432 D1 DE 602006010432D1 DE 602006010432 T DE602006010432 T DE 602006010432T DE 602006010432 T DE602006010432 T DE 602006010432T DE 602006010432 D1 DE602006010432 D1 DE 602006010432D1
Authority
DE
Germany
Prior art keywords
agonists
receptor
carbamate compounds
carbamate
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006010432T
Other languages
English (en)
Inventor
Daniel Long
Seok-Ki Choi
Paul R Fatheree
Adam Goldblum
Daniel Marquess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innoviva Inc
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of DE602006010432D1 publication Critical patent/DE602006010432D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602006010432T 2005-11-22 2006-11-21 Carbamatverbindungen als agonisten am 5-ht4-rezeptor Active DE602006010432D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73870205P 2005-11-22 2005-11-22
PCT/US2006/045099 WO2007062058A2 (en) 2005-11-22 2006-11-21 Carbamate compounds as 5-ht4 receptor agonists

Publications (1)

Publication Number Publication Date
DE602006010432D1 true DE602006010432D1 (de) 2009-12-24

Family

ID=38067868

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006010432T Active DE602006010432D1 (de) 2005-11-22 2006-11-21 Carbamatverbindungen als agonisten am 5-ht4-rezeptor

Country Status (20)

Country Link
US (2) US7329752B2 (de)
EP (1) EP1960396B1 (de)
JP (1) JP2009516745A (de)
KR (1) KR20080072727A (de)
CN (1) CN101312967B (de)
AR (1) AR057627A1 (de)
AT (1) ATE448224T1 (de)
AU (1) AU2006318507A1 (de)
BR (1) BRPI0618835A2 (de)
CA (1) CA2630222A1 (de)
DE (1) DE602006010432D1 (de)
EA (1) EA014819B1 (de)
ES (1) ES2336952T3 (de)
MY (1) MY143574A (de)
NO (1) NO20082597L (de)
NZ (1) NZ567653A (de)
PE (1) PE20070954A1 (de)
TW (1) TW200804366A (de)
WO (1) WO2007062058A2 (de)
ZA (1) ZA200804010B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006094063A1 (en) * 2005-03-02 2006-09-08 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
WO2007097976A1 (en) * 2006-02-16 2007-08-30 Theravance, Inc. Process for preparing intermediates to 5-ht4 receptor agonist compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223511A (en) * 1987-09-23 1993-06-29 Boehringer Ingelheim Italia S.P.A. Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists
IT1231413B (it) 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
JP3829879B2 (ja) * 1994-05-18 2006-10-04 大正製薬株式会社 キノリンカルボン酸誘導体
IT1275903B1 (it) * 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
IT1298271B1 (it) 1998-02-18 1999-12-20 Boehringer Ingelheim Italia Esteri ed ammidi dell'acido 2-oxo-2,3-diidro-benzimidazol-1- carbossilico
CN1461216A (zh) * 1999-04-28 2003-12-10 呼吸器有限公司 用作治疗有关支气管收缩的机能障碍的药物的化合物
IT1313625B1 (it) * 1999-09-22 2002-09-09 Boehringer Ingelheim Italia Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
JP4181847B2 (ja) * 2002-10-25 2008-11-19 エルピーダメモリ株式会社 タイミング調整回路、半導体装置及びタイミング調整方法
ES2377484T3 (es) * 2003-09-03 2012-03-28 Pfizer, Inc. Compuestos de bencimidazolona que tiene actividad agonista del receptor 5-HT
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
ES2332808T3 (es) * 2004-11-05 2010-02-12 Theravance, Inc. Compuestos agonistas del receptor 5-ht4.
EP1807423B1 (de) * 2004-11-05 2009-05-20 Theravance, Inc. Chinolinon-carboxamid-verbindungen
RU2404179C2 (ru) * 2004-12-22 2010-11-20 Тереванс, Инк. Индазол-карбоксамидные соединения
WO2006094063A1 (en) 2005-03-02 2006-09-08 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
US7351304B2 (en) * 2005-05-24 2008-04-01 General Electric Company Method and apparatus for reducing surface defects
DE602006019595D1 (de) 2005-06-07 2011-02-24 Theravance Inc Benzimidazoloncarbonsäureamidverbindungen als agonisten des 5-ht4-rezeptors

Also Published As

Publication number Publication date
AU2006318507A1 (en) 2007-05-31
TW200804366A (en) 2008-01-16
WO2007062058A2 (en) 2007-05-31
CN101312967A (zh) 2008-11-26
ZA200804010B (en) 2009-02-25
US20080090811A1 (en) 2008-04-17
EP1960396A2 (de) 2008-08-27
ATE448224T1 (de) 2009-11-15
PE20070954A1 (es) 2007-09-10
US7851467B2 (en) 2010-12-14
WO2007062058A3 (en) 2007-09-07
US20070117796A1 (en) 2007-05-24
NZ567653A (en) 2011-06-30
CA2630222A1 (en) 2007-05-31
US7329752B2 (en) 2008-02-12
NO20082597L (no) 2008-06-10
BRPI0618835A2 (pt) 2011-09-13
CN101312967B (zh) 2011-08-24
EA200801402A1 (ru) 2008-10-30
KR20080072727A (ko) 2008-08-06
AR057627A1 (es) 2007-12-05
EA014819B1 (ru) 2011-02-28
EP1960396B1 (de) 2009-11-11
ES2336952T3 (es) 2010-04-19
MY143574A (en) 2011-05-31
JP2009516745A (ja) 2009-04-23

Similar Documents

Publication Publication Date Title
ATE549350T1 (de) Neuropeptid-2-rezeptor-agonisten
CY2013047I2 (el) Ενωσεις διαρυλυδαντοϊνης
ATE420088T1 (de) Chinolinoncarbonsäureamidverbindungen als 5-ht4- rezeptoragonisten
DK1863818T3 (da) Acetylenyl-pyrazolo-pyrimidinderivater som mglur2-antagonister
NL1031385A1 (nl) Gesubstitueerde sulfonylaminoarylmethylcyclopropaancarbonamideverbindingen.
DE602006007563D1 (de) Agonisten
FI20050189A0 (fi) Kiinnityssovitelma
ATE479676T1 (de) Als antikoagulanzien verwendbare phenylglycinamid-derivate
ATE513827T1 (de) Oxyindol-derivate als 5ht4-rezeptor-agonisten
DK1973886T3 (da) Prokineticin-1-receptor-antagonister
ATE443056T1 (de) Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
DK1937650T3 (da) Heterocykliske forbindelser
ATE429428T1 (de) Indanderivate als antagonisten des mch-rezeptors
DE502006001027D1 (de) Cyanuraten
ATE535523T1 (de) Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonisten
ES1064680Y (es) Estructura portante de receptor
DE602006015186D1 (de) Oxindole als kinaseinhibitoren
DE502006004891D1 (de) Agrochemische zusammensetzung
FI6681U1 (fi) Palkki
ATE553108T1 (de) Thiazoloä4,5-cüpyridinderivative als antagonisten des mglu5-rezeptors
ATE488519T1 (de) Indol-3-ylcarbonylazaspiroderivate als vasopressinrezeptorantagonisten
DE502006003086D1 (de) Gleitpendellager
DE602006010432D1 (de) Carbamatverbindungen als agonisten am 5-ht4-rezeptor
DE502006002822D1 (de) Ges
FR2884161B1 (fr) Architecture de machine-outil

Legal Events

Date Code Title Description
8364 No opposition during term of opposition